Stocks notched weekly losses on Friday as investors worried the U.S.-China trade war is hurting economic growth.US Marketsread more
The combination of mounting recession fears, bets on a more cautious Fed and a regular uptick in market volatility could spell more losses.Marketsread more
The therapy, Zolgensma, is a one-time treatment for spinal muscular atrophy — a muscle-wasting disease and leading genetic cause of infant mortality, affecting 1 in every...Biotech and Pharmaceuticalsread more
SpaceX has raised just over $1 billion in financing since the beginning of the year.Investing in Spaceread more
An analyst for Ark Invest, which has a major investment in Tesla, says recent drastic price-target cuts by others on Wall Street are missing the big picture.Investingread more
Former Foreign Minister Boris Johnson is seen as the bookmaker's favorite to succeed outgoing Prime Minister Theresa May.Europe Politicsread more
United Airlines will take its 14 Boeing 737 Max jets off its schedule for another month, through Aug. 3, canceling another 1,290 flights.Airlinesread more
Roughly three dozen House Democrats have called for impeachment hearings on President Donald Trump, a billionaire's TV ads rip the House for "doing nothing," and legal experts...Politicsread more
J.P. Morgan economists say they now see a much slower economy in the second quarter, with growth of just 1%.Market Insiderread more
Governor Janet Mills has signed into law a bill that eliminates religious and philosophical exemptions for required vaccinations in Maine.Health and Scienceread more
If consummated, the deal would mark the latest in a flurry of activity in the payment technology space.Banksread more
Dutch health care technology company Philips reported weaker-than-expected third-quarter net income on Monday, citing subdued growth in key markets and foreign currency headwinds.
Here are the key highlights:
"The profit improvement of 40 basis points on the operating income could have been a bit higher if it were not for currency headwinds, which were sizable in the emerging markets. It is something that of course we will compensate as we go forward so not a structural issue," Frans van Houten, CEO of Philips, told CNBC's "Squawk Box Europe" on Monday.
"The other thing that we saw coming is the start of duties and sanctions against, something that we are concerned about, but I want to reiterate that overall Philips is on track to meet its goal of 4 to 6 percent of growth this year," he added.
Despite rising sales and improving margins, Philips posted a profit of 292 million euros ($335 million) for the quarter ending Sept 30. Analysts at data firm Refinitiv had been expecting third-quarter profit to come in at around 350.5 million euros.
Adjusted earnings before interest, tax and amortization (EBITDA) came in at 590 million euros in the third quarter, compared with 532 million in the same period last year.
Revenue increased to 4.31 billion euros from 4.15 billion euros in the same period last year, with comparable sales growth up 4 percent.
Since the separation of its lighting division in 2016, the firm focuses on medical devices and health care products ranging from medical scanners to toothbrushes.
The company also announced Monday it had initiated a share repurchase program for up to 5 million shares. At the current share price, this program is expected to total 174 million euros. It is expected to be completed by November 10.
Shares of Philips are up almost 10 percent year-to-date.